Cullinan Therapeutics to Participate in Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference
CAMBRIDGE, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced that Nadim Ahmed,
Beam Therapeutics to Participate in Guggenheim SMID Cap Biotech Conference
Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer of Beam, plans to participate in a fireside chat during the Guggenheim SMID Cap Biotech Conference on Thursday,
Expat American art collector Peggy Guggenheim dedicated her life to gathering this impressive body of 20th-century contemporary art. The collection, which is housed in the Palazzo Venier dei Leoni ...
Section 19(a) notices are provided for informational ... Consult a professional regarding your specific legal or tax matters. Guggenheim Investments is the global asset management and investment ...
Pentagram’s Harry Pearce was tasked with creating a new logo and wider identity system for the “constellation of museums”, which now spans four locations around the world Founded in 1937, the Solomon ...
The Solomon R. Guggenheim Museum, or simply, "The Guggenheim," is one of the most well-known art museums in the country, and it's just as renowned for its cutting-edge design as it is for its ...
Guggenheim Municipal Income Fund earns a Below Average Process Pillar rating. The process benefits from the parent firm's five-year risk-adjusted success ratio of 57%. The measure indicates the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback